PEGASYS

Google image searchProduct monograph

Active ingredient

peginterferon alfa-2a, 180 MCG/0.5 ML

DIN: 02248077

Dosage form(s): SOLUTION

Route(s) of administration: SUBCUTANEOUS

Description: SINGLE-USE PRE-FILLED SYRINGE

Schedule: Prescription / Schedule D

Company: PHARMAAND GMBH

Date: 03-JUN-2024

ATC:

• L03 — IMMUNOSTIMULANTS (ATC, ATC/DDD, )
• L03A — IMMUNOSTIMULANTS (ATC, ATC/DDD)
• L03AB — Interferons (ATC, ATC/DDD)
• L03AB11 — PEGINTERFERON ALFA-2A (ATC/DDD)

Reference brand drug: Pegasys

Pharmaceutical standard: MFR

External Links for Pegasys

Search on Google

• Pegasys side effects
• Pegasys dosage
• peginterferon alfa-2a side effects
• peginterferon alfa-2a dosage